MAPT and Alzheimer disease: Also, crossing to gene-targeted mice, for the validation of drug targets directly on an AD background [42], or to other transgenic lines, e.g. tau expressing mice, thereby creating a mouse model comprising of both plaques and tangles, may be simplified.